| 2025 | 2024 | |||
|---|---|---|---|---|
| Gross margin | 50,7 k € | -52.5% | 106,7 k € | |
| EBITDA | 49,0 k € | -53.9% | 106,3 k € | |
| Operating profit | 48,6 k € | -54.1% | 105,9 k € | |
| Profit/loss | 48,5 k € | -54.2% | 105,9 k € | |
| Equity | 157,5 k € | +44.5% | 108,9 k € | |
| Total assets | 165,0 k € | +40.4% | 117,5 k € | |
| Cash | 78,1 k € | +255.5% | 22,0 k € | |
| Debts | 7,5 k € | -12.0% | 8,5 k € | |
Source: Belgian Official Gazette
Private limited company · Molenbeek-Saint-Jean · incorporated on 09/02/2024
Private limited company profitable and well capitalised. Cash position rising (+255.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
KA-PHARMA is a Private limited company incorporated in 2024. Its main activity is: Other business support service activities n.e.c.. Its registered office is in Molenbeek-Saint-Jean.